Aytu BioScience Inc

NASDAQ AYTU

Data sourced from iex and EODHD
Download Data

Aytu BioScience Inc Income Statement 2006 - 2024

This table shows the Income Statement for Aytu BioScience Inc going from 2006 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-03-31
Revenue
M 102 107 110 107 104 106 102 97 93 82 74 67 58 53 41 28 14 9 7 7 7 5 4 4 4 4 4 3 3 3 3 3 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - -
Cost of Revenue
M 37 41 43 41 41 43 45 44 44 46 41 36 29 17 12 8 4 2 2 2 2 2 2 2 2 1 2 1 1 1 1 1 1 2 4 6 12 10 8 6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M 65 66 67 67 63 63 58 52 49 36 33 31 30 36 29 20 11 6 5 5 5 2 2 2 1 3 2 2 2 2 2 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - -
Operating Expenses
M 62 70 78 79 75 32 34 54 78 125 116 92 74 59 52 41 30 25 23 22 21 22 21 21 19 17 17 18 30 28 27 23 12 8 5 2 0 0 0 0 0 0 0 0 0 0 0 0 - - - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 31 33 35 37 30 30 30 31 32 38 42 46 51 47 41 35 26 22 20 19 18 17 17 18 18 17 16 18 17 15 13 9 7 6 4 3 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Research and Development (R&D) Expenses
M 2 2 3 4 7 10 13 14 16 12 8 7 4 3 3 2 0 0 1 1 1 1 1 1 1 1 1 1 4 5 6 6 4 4 3 3 7 6 5 4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Expenses
M 29 35 39 38 38 -9 -10 9 30 75 66 40 19 8 8 4 3 3 2 2 2 4 3 3 0 -1 -1 -1 9 9 9 8 0 -2 -2 -3 -8 -6 -5 -4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Costs and Expenses
M 31 37 44 50 44 43 43 44 49 44 40 41 38 42 40 33 26 23 21 20 19 18 17 17 13 14 14 16 21 19 19 15 11 8 3 -1 -10 -10 -8 -6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M 3 -4 -11 -12 -12 31 24 -2 -29 -89 -83 -62 -44 -23 -23 -21 -19 -19 -18 -17 -16 -19 -19 -20 -17 -15 -15 -16 -28 -27 -26 -22 -11 -7 -4 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Expense
M 2 -4 -1 5 26 111 109 147 142 55 55 16 3 3 3 3 1 1 0 0 0 1 1 1 2 2 2 3 2 6 6 5 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Non-operating Income/Expense
M -12 -10 -11 -7 -22 -111 -109 -128 -110 -29 -33 -10 -4 2 11 7 -6 -6 -10 -10 4 8 8 8 3 -1 -1 -1 -8 -8 -8 -9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBT
M -7 -12 -19 -19 -34 -80 -85 -110 -111 -84 -82 -57 -41 -21 -12 -14 -25 -24 -29 -27 -12 -10 -9 -10 -14 -16 -17 -19 -31 -33 -32 -28 -15 -10 -6 -4 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income Tax Provision
M 5 3 6 4 24 113 109 107 87 12 20 12 11 0 -17 -9 11 10 20 20 0 -1 -2 -2 -1 1 1 1 8 8 8 9 0 2 2 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -9 -13 -23 -20 -59 -193 -194 -218 -199 -96 -101 -69 -50 -18 9 -1 -36 -34 -49 -47 -12 -9 -8 -8 -13 -17 -19 -20 -39 -41 -39 -37 -15 -12 -8 -6 -4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-Controlling Interest
M 0 -5 -5 -5 -5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - -
Net Income
M -11 -13 -20 -14 -30 -80 -85 -110 -111 -84 -82 -58 -42 -22 -13 -14 -25 -24 -29 -27 -12 -10 -9 -10 -28 -30 -32 -33 -44 -46 -45 -41 -19 -13 -10 -8 -2 0 0 0 0 0 0 0 - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 5,178,124.00 4,726,430.00 4,124,588.50 3,719,977.75 2,790,120.50 2,229,548.75 1,782,128.50 1,470,681.50 1,315,243.75 1,170,276.50 1,006,144.50 827,870.75 3,679,806.00 3,497,744.50 3,353,643.50 3,231,108.25 102,450.50 69,682.50 55,856.00 38,898.25 901,532.25 890,946.75 883,107.50 881,171.75 1,313.25 615.50 392.25 144.00 104.00 66.75 36.50 24.25 1,497.75 1,492.25 1,491.00 1,532.50 49.75 55,865.00 55,864.75 55,859.75 55,859.50 46.00 46.00 46.00 46.00 46.00 84.00 84.00 83.75 83.50 45.00 35.00 34.75 34.25 34.00 29.00 28.75 28.75 28.75 28.75 28.75 28.75 27.75 27.75 26.75 50.50 50.50 25.75 25.75 1.00 1.00 1.00
EBITDA
M 8 1 -2 -9 -6 40 33 46 31 -13 -5 -27 -20 -16 -25 -20 -10 -11 -5 -4 -9 -9 -8 -9 -10 -11 -11 -12 -18 -17 -17 -13 -10 -9 -6 -4 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation and Amortization
M 5 3 5 6 7 9 9 9 9 13 12 12 13 8 8 6 4 3 3 3 2 2 2 3 2 2 2 3 3 2 2 1 0 -2 -2 -2 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
EBIT
M 6 1 -4 -12 -12 31 24 37 22 -26 -17 -39 -33 -24 -33 -26 -14 -14 -8 -7 -12 -11 -11 -12 -12 -13 -14 -15 -21 -19 -18 -14 -11 -7 -4 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -5.97 -2.77 -66.58 -27.81 -49.61 -95.39 -81.57 -69.71 -41.31 -11.90 -31.65 31.95 43.07 55.24 1,630.03 1,543.81 1,123.85 1,125.27 -36.55 -35.23 -2.42 10.08 14.07 15.49 6.28 -6.43 -11.16 -10.05 -13.43 -12.01 -11.40 -15.52 -1.78 -26.74 84.93 85.27 83.85 106.87 -6.69 -9.26 -10.39 -11.12 -10.52 -6.35 -6.35 -5.99 -4.93 -4.53 -4.14 -1.96 -2.21 -2.55 -4.55 -6.05 -5.18 -5.04 -4.20 -3.42 -4.74 -4.68 -3.06 -3.00 -3.97 -9.64 -33.85 -43.59 -42.44 -36.70 -36.70 -36.70 -53.35 -100.00
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -1 -1 -1 -1 -2 -2 -2 -2 0 0 0 0 0 0 0 - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% 64.11 61.88 60.67 61.87 60.28 59.38 56.22 54.14 52.65 39.18 40.98 44.07 49.34 68.59 73.72 74.89 73.12 72.76 70.22 69.57 72.51 32.17 30.32 30.82 26.88 64.63 56.44 56.24 57.76 54.09 58.45 63.41 72.34 85.09 98.09 75.00 75.00 75.00 66.67 100.00 80.95 80.95 80.95 80.95 100.00 100.00 100.00 100.00 - - - - 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 - - - - - - - - - - -
Operating Income Margin
% 1.58 -5.22 -11.78 -13.30 -13.12 32.33 24.11 -6.14 -34.23 -117.05 -114.05 -93.58 -78.79 -45.89 -75.79 -146.86 -202.76 -233.27 -257.54 -234.98 -271.63 -536.35 -567.97 -609.52 -547.69 -373.68 -410.88 -523.37 -836.54 -821.35 -849.66 -746.91 -687.63 -576.79 -432.31 -331.35 -314.20 -818.31 -1,069.69 -969.96 -826.66 -380.43 -380.43 -793.90 -893.20 -981.20 -981.20 -981.20 - - - - -789.60 -789.60 -789.60 -97.23 47.06 -256.82 -256.82 -682.80 -864.57 - - - - - - - - - - -
Net Income Margin
% -17.21 -15.07 -17.67 -13.67 -27.80 -79.92 -86.04 -115.23 -119.34 -111.72 -114.95 -90.40 -75.47 -44.60 -30.57 -108.91 -315.38 -346.30 -409.49 -384.07 -157.51 -226.29 -248.78 -287.24 -819.22 -849.04 -913.35 -1,019.75 -1,254.20 -1,380.39 -1,406.18 -1,317.91 -1,370.46 -3,031.12 -2,864.01 -2,761.84 -1,957.66 -320.55 -413.58 -236.92 -366.28 41.79 41.79 -388.06 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% 7.57 -1.34 -5.82 -13.55 -6.92 41.16 32.92 48.30 32.91 -18.59 -9.71 -40.44 -34.98 -31.17 -103.57 -156.11 -62.17 -89.81 -73.49 -56.27 -108.00 -204.69 -227.72 -263.81 -291.17 -277.90 -302.47 -400.70 -553.42 -546.21 -596.84 -516.93 -661.72 -2,443.05 -2,303.37 -2,207.92 -2,166.97 -756.17 -988.51 -901.63 -775.08 -344.90 -344.90 -721.05 -817.50 -903.31 -903.31 -903.31 - - - - -650.40 -650.40 -650.40 -86.77 47.11 -206.15 -206.15 -547.66 -712.69 - - - - - - - - - - -
EBIT Ratio
% 2.11 -2.18 -6.37 -13.30 -13.12 32.33 24.41 38.83 22.89 -37.54 -28.94 -60.75 -58.11 -47.60 -124.35 -187.83 -100.71 -131.20 -114.81 -92.22 -149.62 -265.69 -297.02 -338.57 -361.19 -335.84 -373.04 -485.53 -636.50 -621.31 -649.62 -546.87 -687.63 -576.79 -432.31 -331.35 -314.20 -818.31 -1,069.69 -969.96 -826.66 -380.43 -380.43 -793.90 -893.20 -981.20 -981.20 -981.20 - - - - -789.60 -789.60 -789.60 -97.23 47.06 -256.82 -256.82 -682.80 -864.57 - - - - - - - - - - -
EBT Ratio
% -7.01 -11.25 -18.28 -18.89 -33.01 -79.92 -86.04 -115.36 -119.19 -111.57 -114.80 -88.17 -73.51 -42.65 -28.61 -108.91 -315.39 -346.32 -409.50 -384.08 -157.51 -226.29 -248.78 -287.24 -392.96 -422.78 -487.10 -593.49 -910.59 -1,036.78 -1,062.57 -974.30 -862.30 -2,522.96 -2,362.02 -2,255.63 -2,255.21 -877.39 -1,147.82 -1,033.66 -892.19 -412.50 -412.50 -1,649.50 -2,095.26 -3,410.00 -3,410.00 - - - - - -544.74 -544.74 -544.74 1,410.31 1,410.31 637.45 637.45 -726.51 -908.29 - - - - - - - - - - -

StockViz Staff

September 20, 2024

Any question? Send us an email